Matrine could inhibit the activation of RhoA/Rock1 signaling pathway, reduce myocardial fibrosis, prevent ventricular remodeling, and improve cardiac function in rats with heart failure (Sun et al., 2021). The gene discussed is ROCK1; the disease is Myocardial fibrosis.